Диссертация (1139475), страница 37
Текст из файла (страница 37)
–Vol.40. - N4. – 1024 – 1026.466. Sreevatsan S., Stockbauer K.E., Pan X.I. et al. Ethambutol resistance inMycobacterium tuberculosis: critical role of embB mutations // Antimicrob.Agents Chemother. – 1997. – Vol. 41. – P. 1677 -1681.248467. Sumitomo S. Treatment of multi drug resistant tuberculosis // NipponRinsho. - 1998. - Vol. 56. - № 12. - P.
3171-3175.468. Sung S.W., Kang C.H., Kim Y.T. et al. Surgery increased the chance of inmulti-drug resistant pulmonary tuberculosis // Eur. J. Cardiothorac. Surg. 1999.-Vol. 16. - № 2. - P. 187-193.469. Suzuki Y., Katsukawa C., Tamaru A., Abe C., Makino M., Mizuguchi Y.,Taniguchi H. Detection of kanamycin-resistant Mycobacterium tuberculosis byidentifying mutations in the 16S rRNA gene // J.
Clin. Microbiol. - 1998. Vol. –36. – P. 1220 -1225.471. Tacklingdrug-resistantinfectionsglobally:finalreportandrecommendationsthe review onantimicrobial resistancechaired by JimO’Neill, May 2016. https://amr-review.org.472. Tahaoglu K., Torun T., Sevim T., Atac G., Kir A. et al.
The treatment ofmultidrug-resistant tuberculosis in Turkey // N. Engl. J. Med. – 2001. - Vol. 19.- №3. – Р.208-210.473. Takayama K., Kilburn J.O., Inhibition of synthesis of arabinogalactan byethambutol in Mycobacterium smegmatis // Antimicrob. Agents Chemother. 1989. – Vol. 33. – P. 1493 - 1499.474. Takeda S., Maeda H., Hayakawa M. et al. Current surgical intervention forpulmonary tuberculosis // Ann. Thorac. Surg.
– 2005. – Vol. 79. - №3. – P.959-963.475. Takiff, H.E., Salazar, L., Guerrero et al. Cloning and nucleotide sequence ofMycobacterium tuberculosis gyrA and gyrB genes and detection of quinoloneresistance mutations // Antimicrob. Agents Chemother.
- 1994. – Vol. 38. – P.773 - 780.476. Tamimi T., Hankins J., Miller J. et al. The value of thoracoplasty beforeextensive unilateral resection for pulmonary tuberculosis // Am. Surg. – 1976. –Vol. 42. - № 1.– P. 71-74.477. Tang S. et al. Risk factors for poor treatment outcomes in patients with MDRTB and XDR-TB in China: retrospective multi-centerinvestigation. PLoS ONE249Electron Resour. 8, e82943, https://doi.org/10.1371/journal.pone.0082943(2013).478. Telenti A., Philipp W.J., Sreevatsan S. et al. The emb operon, a unique genecluster of Mycobacterium tuberculosis involved in resistance to ethambutol //Nat.
Med. – 1997. – Vol. 3. – P. 567 - 570.479. Telzak E.E.,Chirgwin K.D., Nelson E.T.et al.Predictors formultirug-rssistant tuberculosis among HIV-infected patients and response tocific drug regimens // Int. J. Tuberc. Lung Dis. - 1999. - Vol. 3. - № 4. - P. 337343.480. Thomas J.P., Baughn C.O., Wilkinson R.G. and Shepherd R.G. A NewSynthetic Compound with Antituberculous Activity in Mice: Ethambutol(Dextro-2, 2 ′ - (Ethylenediimino)-di-1-Butanol) //American Review ofRespiratory Disease. – 1961. - Vol. 83. - № 6. - P. 891–893.481.
Tortoli E. Clinical validation of Xpert MTB/RIF for the diagnosis ofextrapulmonary tuberculosis / E. Tortoli, C. Russo, C. Piersimoni et al. //European Respiratory Journal. – 2012. – Vol. 40 (2). – P. 442–447.482. Torun T. Side effects associated with the treatment of multi-drug resistanttuberculosis / T. Torun, O. Gungor, I.
Ozmen, Y. Bolukbasi, E. Maden, B.Bicakci // Int J Tuberc Lung Dis. ‒ 2005. ‒ Vol. 9. ‒ P. 1373–7.483. Traore H., Fissette K., Bastian I., Devleeschouwe M., Portaels F. Detectionof rifampicin resistance in Mycobacterium tuberculosis isolates from diversecountries by a commercial line probe assay as an initial indicator of multidrugresistance // Int. J. Tuberc. Lung.
Dis. - 2000. - Vol. 4. - № 5. – P. 481–484.484. Treasure R.L., Seaworth B.J. Current role of surgery in Mycobacteriumtuberculosis. Ann Thorac Surg 1995; 59: 1405–07.485. Tsukamura M., Mizuno S. Cross-resistance Relationships among theAminoglucoside Antibiotics in Mycobacterium tuberculosis. First PublishedOnline: 01 June 1975, Microbiology 88: 269-274. doi:10.1099/00221287-88-2269.http://mic.microbiologyresearch.org/content/journal/micro/10.1099/00221287-88-2-269.250486. Tsuyuguchi I.Immunotherapy for MDR-TB(multi-drug resistanttuberculosis)-its feasibility // Kekkaku.
- 1999. - Vol. 74. - № 6. - P. 479-491.487. Tsuyuguchi K. Multidrug-resistant tuberculosis. Additional comment:primary multidrug-resistant tuberculosis—diagnosis and treatment // Kekkaku. 1998. - Vol. 73. - № 11. - P. 687-690.488. Umezawa H., Ueda M., Maeda K. et al. Production and isolationofanewantibiotic, kanamycin// J. Antibiot. – 1957. – Vol.
10А. – P. 181-188.489. Van Altena R. et al. Highly successful treatment outcome of multidrugresistant tuberculosis in the Netherlands, 2000–2009. JTuberc. 19, 406–412(2015).490. Van Der Walt M., Lancaster, J. & Shean, K. Tuberculosis case fatality andother causes of death among multidrug-resistanttuberculosis patients in a highHIV prevalence setting, 2000–2008, South Africa. PLoS ONE. 11, e0144249,https://doi.org/10.1371/journal.pone.0144249 (2016).491.
Van Leuven M., De Groot M, Shean K.P. et al. Pulmonary resection as anadjunct in the treatment of multiple drug-resistant tuberculosis // Ann. Thorac.Surg. - 1997. - Vol. 63. - № 5. - P. 1368-1372.492. Vaniyev E. V. Side effects of antituberculosis drugs at treatment of patientswith newly detected pulmonary tuberculosis / E.V. Vaniyev, R.Y. Abdullayev,O.G. Komissarova, I.A. Vasilyeva // Eur. Respir. J. – 2007. – Vol.
30 (Suppl.51). – P. 197s.493. Varaine F. Tuberculosis. Practical guide for clinicians, nurses, laboratorytechnicians and medical auxiliaries / F. Varaine, M.L. Rich // Medecins SansFrontiere. – 2013. – P. 37-38.494. Variations of Subunit ε of the Mycobacterium tuberculosis F1Fo ATPSynthase and a Novel Model for Mechanism of Action of the TuberculosisDrug TMC207 / Biukovic, G., Basak, S., Manimekalai et al. // Antimicrobialagents and chemotherapy.
- 57(1). – P. 168-176.251495. Vashakidze S. et al. Favorable outcomes for multidrug and extensively drugresistant tuberculosis patients undergoing surgery. AnnThorac Surg. 95, 1892–1898 (2013).496. Vasuiky Kano. Eine Untersuchung űber die Ergebnisse chirurgischerverfahren bei lungen tuberkulose aus 157 Statlichen Sanatorien Japans // Ztschr.F.
Tuberk. – 1963. – Bd. 119. – H. 5/6. – S. 273-283.497. Vencevicius V., Serpytis J., Grazelis E. et. al. Surgical approach to lungtuberculosis // Medicina (Kaunas). – 2004. - Vol. 40. – Suppl. 1. – P. 142-144.498. Verma R. Adverse drug reactions associated with first-line anti-tuberculardrugs in a tertiary care hospital of central india: a study of clinicalpresentations, causality, and severity / R. Verma, G.
R. Mahor, A. K.Shrivastava, P. Pathak // Asian J Pharm Clin Res. – 2014. – Vol. 7. – №5. – P.140–143.499. Vieira D. E. Adverse effects of tuberculosis treatment: experience at anoutpatient clinic of a teaching hospital in the city of São Paulo, Brazil / D. E.Vieira, M. Gomes // J Bras Pneumol. – 2008. – Vol. 34. – №12. – р. 1049–55.500. Vilariça A. S., Diogo N., André M., Pina J. Adverse reactions toantituberculosis drugs in in-hospital patients: severity and risk factors / A. S.Vilariça, N.
Diogo, M. André, J. Pina // Rev. Port. Pneumol. – 2010. – Vol. 16.– №3. – P. 431–51.501. Vilchèze C. et al. Transfer of a point mutation in Mycobacteriumtuberculosis inhA resolves the target of isoniazid // Nat. Med. -2006. – Vol.12.– P. 1027 - 1029.502. Wada M., Mizutani S., Nakajima Y., Ito K. et al. A case of multidrugresistant pulmonary tuberculosis cured by the regimen including thiacetazone //Kekkaku.
– 2007. – Vol. 82. – P. 33-37.503. Wade M. M., Zhang Y. Mechanisms of drug resistance in Mycobacteriumtuberculosis // Front. Biosci. 2004. Vol. 9. P. 975–994.252504. Wang H, Lin H, Jiang G. Pulmonary resection in the treatment of multidrugresistant tuberculosis: a retrospective study of 56 cases. Ann Thorac Surg 2008;86: 1640–45.505. Weissberg D. The place of surgery in today’s treatment of pulmonarytuberculosis // Surgery of tuberculosis. Abstracts Moscow internationalconference.
– 1997. – P. 39-40.506. WHO Regional Office for Europe consensus paper: The role of surgery in thetreatment of pulmonary TB and multidrug- and extensively drug-resistant TB, 2014. http://www.euro.who.int/__data/assets/pdf_file/0005/259691/The-role-ofsurgery-in-the-treatment-of-pulmonary-TB-and-multidrug-and-extensivelydrug-resistant-TB.pdf.507. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update.October 2016 revision.
- Geneva: World Health Organization, - 2016.508. WHO/IUATLD global working group on antituberculosis drug resistancesurveillance // Int. J. Tuberc. Lung Disease. – 1998. – Vol. 2, № 1. – P.72-89.509. Wilkinson R.G., Shepherd R.G., Thomas J.P., Boughn C.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
